Upwards arrow: Go back to top

Join us on LinkedIn for the latest news.

News & Press

Learn more about recent advances in biotech, health tech and our work.

Auron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ Platform
8.2.2024
Auron Selects First Development Candidate from its Novel AURIGIN™ Platform
HAYA Therapeutics wins Swiss Startup Award
7.9.2023
HAYA Therapeutics wins the top prize at the TOP 100 Swiss Startup Award 2023
Bloom Science Announces Positive Topline Data
17.8.2023
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS
Auron Establishes Premier Scientific Advisory Board
1.8.2023
Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer
Focal Biosciences
20.7.2023
Focal Biosciences: new cellular reprogramming startup unveiled
HAYA changing RNA therapies
5.7.2023
Junk DNA: how the dark genome is changing RNA therapies
Apollo Health Ventures Gründerszene
29.6.2023
Megatrend Biotech: Dieser Investor kennt fünf Startups mit blendenden Aussichten
Defining a Longevity Biotechnology Company
26.6.2023
The Longevity Biotechnology Association (LBA): Defining a Longevity Biotechnology Company